Search research articles
Contact Us
Filters
Showing results (231-240 of 298) with videos related to
Page
of 30
Sort By:
Nature Communications
|
July 12, 2020
Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling
Federico N Soria, Chiara Paviolo, Evelyne Doudnikoff, et al.
NPJ Parkinson'S Disease
|
May 11, 2026
Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseases
Sonia S Muñoz, Frederik R Marlet, Jesper E Dreier, et al.
The Lancet. Neurology
|
June 8, 2015
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, et al.
Biological Psychiatry
|
August 23, 2014
Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia
Michel Engeln, Matthieu F Bastide, Estelle Toulmé, et al.
Nature Methods
|
September 25, 2019
Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging
Mohammadreza Shariatgorji, Anna Nilsson, Elva Fridjonsdottir, et al.
Neurobiology of Disease
|
March 9, 2010
Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex
Markus Storvik, Marie-Jeanne Arguel, Sandra Schmieder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice
Tiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.
Journal of Neurochemistry
|
April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesia
Anthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 24, 2016
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
François Tison, Charlotte Keywood, Mark Wakefield, et al.
Neurobiology of Disease
|
May 23, 2020
Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates
Alexander Maxan, Giacomo Sciacca, Melanie Alpaugh, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 298) with videos related to
Sort By:
Page
of 30
Nature Communications
|
July 12, 2020
Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling
Federico N Soria, Chiara Paviolo, Evelyne Doudnikoff, et al.
NPJ Parkinson'S Disease
|
May 11, 2026
Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseases
Sonia S Muñoz, Frederik R Marlet, Jesper E Dreier, et al.
The Lancet. Neurology
|
June 8, 2015
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, et al.
Biological Psychiatry
|
August 23, 2014
Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia
Michel Engeln, Matthieu F Bastide, Estelle Toulmé, et al.
Nature Methods
|
September 25, 2019
Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging
Mohammadreza Shariatgorji, Anna Nilsson, Elva Fridjonsdottir, et al.
Neurobiology of Disease
|
March 9, 2010
Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex
Markus Storvik, Marie-Jeanne Arguel, Sandra Schmieder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice
Tiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.
Journal of Neurochemistry
|
April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesia
Anthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 24, 2016
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
François Tison, Charlotte Keywood, Mark Wakefield, et al.
Neurobiology of Disease
|
May 23, 2020
Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates
Alexander Maxan, Giacomo Sciacca, Melanie Alpaugh, et al.
Page
of 30